Tocagen Inc (TOCA) SEC Filing 8-K Material Event for the period ending Tuesday, October 1, 2019

Tocagen Inc

CIK: 1419041 Ticker: TOCA

View differences made from one to another to evaluate Tocagen Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Tocagen Inc.


Assess how Tocagen Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Tocagen Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Tocagen Inc provided additional information to their SEC Filing as exhibits

Ticker: TOCA
CIK: 1419041
Form Type: 8-K Corporate News
Accession Number: 0001564590-19-036313
Submitted to the SEC: Thu Oct 03 2019 6:02:22 AM EST
Accepted by the SEC: Thu Oct 03 2019
Period: Tuesday, October 1, 2019
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. New Costs
  3. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: